GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qingdao NovelBeam Technology Co Ltd (SHSE:688677) » Definitions » PEG Ratio

Qingdao NovelBeam Technology Co (SHSE:688677) PEG Ratio : 2.33 (As of May. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Qingdao NovelBeam Technology Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Qingdao NovelBeam Technology Co's PE Ratio without NRI is 39.86. Qingdao NovelBeam Technology Co's 5-Year EBITDA growth rate is 17.10%. Therefore, Qingdao NovelBeam Technology Co's PEG Ratio for today is 2.33.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Qingdao NovelBeam Technology Co's PEG Ratio or its related term are showing as below:

SHSE:688677' s PEG Ratio Range Over the Past 10 Years
Min: 2.14   Med: 2.41   Max: 2.68
Current: 2.33


During the past 9 years, Qingdao NovelBeam Technology Co's highest PEG Ratio was 2.68. The lowest was 2.14. And the median was 2.41.


SHSE:688677's PEG Ratio is ranked worse than
57.14% of 245 companies
in the Medical Devices & Instruments industry
Industry Median: 1.98 vs SHSE:688677: 2.33

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Qingdao NovelBeam Technology Co PEG Ratio Historical Data

The historical data trend for Qingdao NovelBeam Technology Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao NovelBeam Technology Co PEG Ratio Chart

Qingdao NovelBeam Technology Co Annual Data
Trend Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only - - - 2.72 2.77

Qingdao NovelBeam Technology Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 2.77 -

Competitive Comparison of Qingdao NovelBeam Technology Co's PEG Ratio

For the Medical Instruments & Supplies subindustry, Qingdao NovelBeam Technology Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qingdao NovelBeam Technology Co's PEG Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qingdao NovelBeam Technology Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Qingdao NovelBeam Technology Co's PEG Ratio falls into.



Qingdao NovelBeam Technology Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Qingdao NovelBeam Technology Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=39.858906525573/17.10
=2.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Qingdao NovelBeam Technology Co  (SHSE:688677) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Qingdao NovelBeam Technology Co PEG Ratio Related Terms

Thank you for viewing the detailed overview of Qingdao NovelBeam Technology Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Qingdao NovelBeam Technology Co (SHSE:688677) Business Description

Traded in Other Exchanges
N/A
Address
No. 100, Weisi Road, Keyuan, Laoshan District, Shandong Province, Qingdao, CHN, 266100
Qingdao NovelBeam Technology Co Ltd is engaged in the research and development, production and sales of medical endoscope equipment and optical products. The product portfolio of the group includes Endoscope, Camera coupler, Camera lens, Medical optics, Biometrics and others.
Executives
Wang Fang Hua senior management
Mao Rong Zhuang Core technical personnel
Zheng Jin Lan Supervisors

Qingdao NovelBeam Technology Co (SHSE:688677) Headlines

No Headlines